Aqueous humor-borne factor upregulates Bcl-2 expression in corneal endothelial cells

Current Eye Research

Volumn 17, Issue 10, 1998, Pages 970-978

  Li, Xiao Yan ^a   De Marco, Brendan M ^a   Mayhew, Elizabeth S ^a   Niederkorn, Jerry Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Aqueous humor; Bax; Bcl 2; Corneal endothelial cells; Human; Mouse

Indexed keywords

FAS ANTIGEN; PROTEIN BCL 2; PROTEINASE;

ANIMAL CELL; APOPTOSIS; AQUEOUS HUMOR; ARTICLE; CELL CULTURE; CELL IMMORTALIZATION; CONTROLLED STUDY; CORNEA ENDOTHELIUM; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MITOSIS; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; TRANSCRIPTION REGULATION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; AQUEOUS HUMOR; BCL-2-ASSOCIATED X PROTEIN; BIOLOGICAL FACTORS; BLOTTING, NORTHERN; CELLS, CULTURED; CILIARY BODY; DNA; DNA PRIMERS; DNA PROBES; ENDOTHELIUM, CORNEAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENES, BCL-2; HUMANS; IN SITU NICK-END LABELING; IRIS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NZB; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RABBITS; RECEPTORS, TUMOR NECROSIS FACTOR; UP-REGULATION;

EID: 0031698206     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.17.10.970.5240     Document Type: Article

References (38)

1. Nishida T. Cornea. In: Krachemer JH, Mannis MJ and Holland EJ, eds. Cornea: Fundamentals of Cornea and External Disease St. Louis, MO: Mosby; 1997:3-28.
2. Cohen JJ. Apoptosis: physiologic cell death. J Lab Clin Med. 1994;124:761-765.
3. Hoffman B, Liebermann DA. Molecular controls of apoptosis: differentiation/growth arrest primary response genes, proto-oncogenes, and tumor suppressor genes as positive and negative modulators. Oncogene. 1994;9:1807-1812.
4. Lynch DH, Ramsdell F, Alderson MR. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today. 1995;16:569-574.
5. Green DR, Martin SJ. The killer and the executioner: how apoptosis controls malignancy. Curr Opinion Immunol. 1995;7:694-703.
6. White K, Grether ME, Abrams JM, Young L, Farrell K, Steller H. Genetic control of programmed cell death in Drosophila. Science. 1994;264:677-683.
7. Reed JC. Double identity for proteins of the Bcl-2 family. Nature. 1997;387:773-776.
8. Chen J, Flannery JG, LaVail MM, Steinberg RH, Xu J, Simon MI. (1996) Bcl-2 over expression reduces apoptotic photoreceptor cell death in three different retinal degenerations. Proc Natl Acad Sci USA. 1996;93:7042-7047.
9. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1-6.
10. Gougeon M-L., Montagnier L. Apoptosis in AIDS. Science. 1993;260:1269-1270.
11. Baffy G, Miyashita T, Williamson JR, Reed JC. Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-2-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J Biol Chem. 1993; 268:6511-6519.
12. 2++ fluxes. Proc Natl Acad Sci USA. 1994; 91:6569-6573.
13. Ryan JJ, Prochownik E, Gottlieb CA, et al. C-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci USA. 1994;91:5878-5882.
14. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-619.
15. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 1995;270:1189-1192.
16. Griffith TS, Yu X, Herndon JM, Green DR, Ferguson TA. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity. 1996;5:7-16.
17. Wilson SE, Li Q, Weng J, Barry-Lane PA, Jester JV, Liang Q, et al. The Fas-Fas ligand system and other modulators of apoptosis in the cornea. Invest Ophthamol Vis Sci. 1996;37:1582-1592.
18. He YG, McCulley J. Growing human corneal epithelium on collagen shield and subsequent transfer to denuded cornea in vitro. Curr Eye Res. 1991;10:851-863.
19. Wilson SE, Weng J, Blair S, He YG, Lloyd S. Expression of E6/E7 or SV40 large T antigen-coding oncogenes in human corneal endothelial cells indicates regulated high-proliferative capacity. Invest Ophthalmol Vis Sci. 1995;36: 32-40.
20. Streilein, JW, Bradley D. Analysis of immunosuppressive properties of iris and ciliary body and their secretory products. Invest Ophthalmol Vis Sci. 1991;32:2700-2710.
21. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 1991;139:271-279.
22. Shima Y, Nishimoto N, Ogata A, Fujii Y, Yoshizaki K, Kishimoto T. Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis. Blood. 1995;85:757-764.
23. Allsopp TE, Wyatt ES, Paterson HF, Davies AM. The protooncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell. 1993;73: 295-307.
24. Garcia I, Martinou I, Tsujimoto Y, Martinou J-C. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science. 1992;258:302-304.
25. Itoh N, Tsujimoto Y, Shigekazu N. Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol. 1993;151:621-627.
26. Rodriguez I, Matsuura K, Khatib K, Reed JC, Nagata S, Vassalli P. A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody rejection. J Exp Med. 1996;183:1031-1036.
27. Rao NA, Thaete LG, Delmage M, Sevanian A. Superoxide dismutase in ocular structures. Invest Ophthalmol Vis Sci. 1985;26:1778-1781.
28. Atalla L, Fernandez MA, Rao NA. Immunohistochemical localization of catalase in ocular tissue. Curr Eye Res. 1987;6:1181-1187.
29. Armstrong D, Santangelo G, Connole E. The distribution of peroxide regulating enzymes in the canine eye. Curr Eye Res. 1981;1:225-242.
30. Atalla LR, Sevanian A, Rao NA. Immunohistochemical localization of glutathione peroxidase in ocular tissue. Curr Eye Res. 1988;7:1023-1027.
31. Bora NS, Gobleman CL, Atkinson JP, Pepose JS, Kaplan HJ. Differential expression of the complement regulatory proteins in the human. Invest Ophthalmol Vis Sci. 1993;34: 3579-3584.
32. Granstein RD, Staszewski R, Knisely TL, et al. Aqueous humor contains transforming growth factor-β and a small (<3500 daltons) inhibitor of thymocyte proliferation. J Immunol 1990;144:3021-3027.
33. Cousins SW, McCabe M, Danielpour D, Streilein JW. Identification of transforming growth factor-β as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci. 1991;32:2201-2211.
34. Jampel HD, Roche N, Stark WJ, Roberts AB. Transforming growth factor-β in human aqueous humor. Curr Eye Res. 1990;9:963-969.
35. Taylor AW, Streilein JW, Cousins SW Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res. 1992;11:1199-1206.
36. Wahlestedt C, Beding B, Ekman R, Oksala O, Stjernschantz J, Hakanson R. Calcitonin gene-related peptide in the eye: release by sensory nerve stimulation and effects associated with neurogenic inflammation. Reg Peptides. 1986;16:107-115.
37. Ferguson TA, Fletcher S, Herndon J, Griffith TS. Neuropeptides modulate immune deviation induced via the anterior chamber of the eye. J Immunol 1995;155:1746-1756.
38. Taylor AW, Streilein JW, Cousins SW Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J Immunol. 1994;153:1080-1086.